Antihypertensive drug use and breast cancer risk: a meta-analysis of observational studies.

Oncotarget · 2017 · PMC5617528 · PMID 28977968

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

borderline significantno p-value reported

This finding is consistent with a prior Seattle-Puget Sound case-control study, which identified a borderline significant risk reduction for lobular breast cancers among women using ACEis for 10 years or longer (RR = 0.6, 95% CI: 0.4-1.0) [ 2 ].

also in 11,409 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.